Mark Lamotte
Corporate Village
Zaventem, VLG, Belgium
Zaventem, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
The cost-effectiveness of subcutaneous semaglutide 2.4 mg in the management of people living with obesity and prediabetes in England.
Journal: Journal of medical economics
Published: October 15, 2025
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes.
Journal: Applied health economics and health policy
Published: August 20, 2024
Cost-effectiveness of empagliflozin as add-on to standard of care for chronic kidney disease management in the United Kingdom.
Journal: Journal of medical economics
Published: May 17, 2024
The cost-effectiveness of a bimekizumab versus IL-17A inhibitors treatment-pathway in patients with active axial spondyloarthritis in Scotland.
Journal: Journal of medical economics
Published: April 23, 2024
Cost-effectiveness of semaglutide 2.4 mg in chronic weight management in Portugal.
Journal: Diabetology & metabolic syndrome
Published: March 14, 2024
Smart connected insulin dose monitoring technologies versus standard of care: a Canadian cost-effectiveness analysis.
Journal: Journal of comparative effectiveness research
Published: January 11, 2024
Examining the Impact of Structural Uncertainty Across 10 Type 2 Diabetes Models: Results From the 2022 Mount Hood Challenge.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: January 09, 2024
Burden of Illness of Type 2 Diabetes Mellitus in the Kingdom of Saudi Arabia: A Five-Year Longitudinal Study.
Journal: Advances in therapy
Published: November 03, 2023
Assessing the health and economic burden of obesity-related complications in East-Asian populations: implementation of risk equations in the Core Obesity Model for Japan and model validation.
Journal: BMJ public health
Published: June 15, 2023
Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States.
Journal: Journal of managed care & specialty pharmacy
Published: May 03, 2023
Last Updated: 09/26/2026